SCHEMBL3170204

SCHEMBL3170204

CC(=O)NCCNc1cc(NC(=O)C(=O)N2CCN(c3ccccc3F)CC2)nc(-c2ccccc2)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.43
▸ SMN1; SMN2 Q16637 4/20 0.42
▸ ALDH1A1 P00352 3/20 0.42
▸ LMNA P02545 2/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ KDM4E B2RXH2 2/20 0.41
▸ ALOX15 P16050 1/20 0.41
▸ ADORA2A P29274 3/20 0.41
▸ ADORA1 P30542 3/20 0.41
▸ ADORA2B P29275 2/20 0.41
▸ ADORA3 P0DMS8 2/20 0.41
▸ ADRA1A P35348 2/20 0.40
▸ MAPK1 P28482 2/20 0.40
▸ NPSR1 Q6W5P4 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ DRD2 P14416 1/20 0.40
▸ DRD3 P35462 1/20 0.40
▸ HTR1A P08908 1/20 0.40
▸ ADRA1D P25100 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3156119 0.93 PHGDH (0.42) KMT2ASMN1; SMN2ALDH1A1LMNANPC1
SCHEMBL3156223 0.90 KMT2A (0.42) KMT2ASMN1; SMN2ALDH1A1LMNANPC1
SCHEMBL3164424 0.90 ADORA2A (0.41) KMT2AALDH1A1ALOX15ADORA2AADORA1
SCHEMBL3166495 0.88 SLC1A2 (0.44) KMT2AALDH1A1LMNAKDM4EALOX15
SCHEMBL3175820 0.88 MEN1 (0.46) KMT2AALDH1A1KDM4EADRA1AMEN1
SCHEMBL3165360 0.88 PHGDH (0.43) ALDH1A1LMNAKDM4EALOX15ADORA2A
SCHEMBL3163864 0.88 LMNA (0.43) KMT2AALDH1A1LMNAKDM4EADORA2A
SCHEMBL3175769 0.87 ADORA2A (0.45) ALDH1A1LMNAKDM4EALOX15ADORA2A
SCHEMBL3170498 0.86 TSHR (0.41) KMT2AALDH1A1LMNAKDM4EALOX15
SCHEMBL3155892 0.86 ADORA2A (0.46) ALDH1A1LMNAKDM4EALOX15ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 — — EP disclosed
Send feedback